Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06547775
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-02
Brief Title:
A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Double-blind and Placebo-controlled Phase I Clinical Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of KN069 in Chinese Male Participants With Obesity or Overweight
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 1 First-in-human double-blinded placebo-controlled study which aims to investigate the safety tolerability pharmacokinetics PK pharmacodynamics PD and the immunogenicity of KN069 in Chinese male participants with Obesity or Overweight
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None